AccuStem Sciences, Inc. (ACUT)
OTCMKTS · Delayed Price · Currency is USD
0.474
0.00 (0.00%)
At close: Jan 17, 2025

AccuStem Sciences Statistics

Total Valuation

AccuStem Sciences has a market cap or net worth of 4.16 million. The enterprise value is 4.18 million.

Market Cap 4.16M
Enterprise Value 4.18M

Important Dates

The next estimated earnings date is Friday, February 14, 2025.

Earnings Date Feb 14, 2025
Ex-Dividend Date n/a

Share Statistics

AccuStem Sciences has 11.35 million shares outstanding. The number of shares has decreased by -0.01% in one year.

Current Share Class n/a
Shares Outstanding 11.35M
Shares Change (YoY) -0.01%
Shares Change (QoQ) n/a
Owned by Insiders (%) 41.70%
Owned by Institutions (%) n/a
Float 5.28M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -3.03
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.03

Current Ratio 0.03
Quick Ratio 0.01
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -476.99%
Return on Capital (ROIC) n/a
Revenue Per Employee n/a
Profits Per Employee -459,681
Employee Count 3
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -20.96% in the last 52 weeks. The beta is 3.03, so AccuStem Sciences's price volatility has been higher than the market average.

Beta (5Y) 3.03
52-Week Price Change -20.96%
50-Day Moving Average 0.35
200-Day Moving Average 0.46
Relative Strength Index (RSI) 49.23
Average Volume (20 Days) 12,647

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.56

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -1.38M
Pretax Income -1.38M
Net Income -1.38M
EBITDA -1.38M
EBIT -1.38M
Earnings Per Share (EPS) -0.12
Full Income Statement

Balance Sheet

The company has 37,080 in cash and 57,597 in debt, giving a net cash position of -20,517 or -0.00 per share.

Cash & Cash Equivalents 37,080
Total Debt 57,597
Net Cash -20,517
Net Cash Per Share -0.00
Equity (Book Value) -3.19M
Book Value Per Share -0.28
Working Capital -3.19M
Full Balance Sheet

Cash Flow

Operating Cash Flow -959,511
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

AccuStem Sciences does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 0.01%
Shareholder Yield 0.01%
Earnings Yield -33.12%
FCF Yield n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score n/a